MOH — authorised 5 February 2014
- Marketing authorisation holder: SANDOZ
- Status: likely_approved
MOH authorised Cefpodoxime Proxetil on 5 February 2014
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 5 February 2014; MOH has authorised it.
SANDOZ holds the UAE marketing authorisation.